Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.46
0.021.39%
At close: -
$1.44
-0.02-1.27%
After Hours: 7:50 PM EDT
Comments
Loading...
Outlook Therapeutics Stock Price, Quotes and Forecasts
OTLKNASDAQ
Outlook Therapeutics (OTLK) Forecast
NewsEarningsOptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestStock ReportEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Outlook Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:OTLK | Benzinga
Explore Outlook Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OTLK.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Outlook Therapeutics (OTLK) stock?
You can purchase shares of Outlook Therapeutics (NASDAQ:OTLK) through any online brokerage.
Who are Outlook Therapeutics (OTLK) competitors?
Other companies in Outlook Therapeutics’s space includes: Estrella Immunopharma (NASDAQ:ESLA), Aligos Therapeutics (NASDAQ:ALGS), Barinthus Biotherapeutics (NASDAQ:BRNS), OS Therapies (AMEX:OSTX) and Cue Biopharma (NASDAQ:CUE).
What is the forecast, or price target, for Outlook Therapeutics (OTLK) stock?
Outlook Therapeutics has a consensus price target of $4.08.
What is the current price for Outlook Therapeutics (OTLK)?
The stock price for Outlook Therapeutics (NASDAQ: OTLK) is $1.4414 last updated October 15, 2025 at 7:50 PM EDT.
Does Outlook Therapeutics (OTLK) pay a dividend?
There are no upcoming dividends for Outlook Therapeutics.
When is Outlook Therapeutics (NASDAQ:OTLK) reporting earnings?
Outlook Therapeutics’s Q4 earnings are confirmed for Friday, December 26, 2025.
Is Outlook Therapeutics (OTLK) going to split?
There is no upcoming split for Outlook Therapeutics.
What sector and industry does Outlook Therapeutics (OTLK) operate in?
Outlook Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
